Understanding Lung Cancer

How Long Will I Live With Lung Cancer? 

Last updated and reviewed on May 15, 2026. 

If you or someone you love has just been diagnosed with lung cancer, it is completely normal to have questions about the future. One of the most common and important questions people ask is: How long will I live? The honest answer is that it depends on many things, including what type of lung cancer you have, how early it was found, and what treatments are available to you. This guide will help explain what we know about lung cancer, what the survival numbers mean, and why there is real reason for hope.

This page also includes information about survival rates. For many people, their first question after a lung cancer diagnosis is “what is my prognosis?” or “how long will I live after a lung cancer diagnosis?” But it is important to remember that every person is different, and researchers are always studying new treatments.

How common is lung cancer?

Lung cancer is one of the most common cancers in the United States. In fact, doctors expect about 229,410 new cases of lung cancer to be diagnosed in the U.S. in 2026 alone ¹. That means roughly 1 in every 18 Americans will be diagnosed with lung cancer at some point in their lifetime, about 5.4% of all men and women. Right now, there are an estimated 635,000 people in the United States living with lung cancer ².

Lung cancer affects both men and women. For a long time, it was thought of mainly as a disease that affected men, but rates in women have not been falling as quickly. In fact, while the number of new lung cancer cases in men has been going down steadily, cases in women have been declining more slowly ³.

While lung cancer is the third most common cancer diagnosis in the United States (behind prostate and breast cancer), it causes more deaths than any other cancer. Every year, more people die from lung cancer than from colorectal cancer, breast cancer, and pancreatic cancer combined ⁴. That is why finding it early and getting treatment right away matters so much.

The good news is that rates of new lung cancer cases have been falling by about 2.4% per year over the past decade, and death rates have been falling even faster, about 4.2% per year ⁵. This means fewer people are getting lung cancer and, importantly, more people are surviving it. These improvements are largely due to fewer people smoking, better screening tools, and new treatments.

What is the survival rate of lung cancer?

Survival rates are numbers that doctors use to describe how many people with a certain cancer are still alive after a set amount of time, usually 5 years. These numbers come from large groups of patients and can help give you a general idea of what to expect, but they cannot predict exactly what will happen to any one person.

For lung cancer overall, survival rates have been improving. One important study predicted that the 5-year survival rate for lung cancer patients may now be approaching 38.7% for recently diagnosed patients, a big jump from just 23.8% for patients diagnosed around 2013 ⁶. In the United States, survival rates vary a lot depending on what stage the cancer is in when it is first found.

Stage, meaning how far the cancer has spread in the body, is the biggest factor affecting survival. When lung cancer is found early (called "localized" stage), before it has spread outside the lungs, the 5-year survival rate is about 60.6% ⁷. Unfortunately, only about 1 in 4 lung cancer patients are diagnosed at this early stage. When the cancer has spread to nearby lymph nodes or tissues (called "regional" stage), survival is lower. When it has spread to distant parts of the body (called "distant" stage), survival is harder to achieve, though even here, newer treatments are making a difference.

The key message is this: the earlier lung cancer is found, the better the chances of surviving. This is why lung cancer screening using a special low-dose CT scan is so important for people who are at higher risk, such as long-time smokers or former smokers over a certain age. Catching cancer early, when it is still in the lungs and has not spread, gives treatments their best chance to work.

Is lung cancer curable?

Yes, for some patients, lung cancer can be cured, especially when it is found at an early stage. When a small tumor is discovered before it has spread, surgery to remove it can sometimes eliminate the cancer completely. For early-stage non-small cell lung cancer (the most common type), surgery is often the main treatment, and it can lead to a cure in many cases. Radiation therapy and other treatments may also be used after surgery to lower the chances of the cancer coming back.

Even for more advanced stages of lung cancer, the word "cure" may not always apply in the traditional sense, but many patients are able to live for years with their cancer well-controlled. In recent years, medicine has made remarkable progress. New treatments called targeted therapies are designed to attack specific changes (called mutations) in cancer cells. If your cancer has certain gene mutations, such as in the EGFR or ALK genes, targeted drugs can be very effective at stopping the cancer from growing, even in advanced stages. Doctors now routinely test lung cancer cells for these mutations to find the best treatment for each patient.

Another major breakthrough is immunotherapy treatments that help your own immune system find and fight the cancer. Immunotherapy has been a game-changer for many lung cancer patients, including those with advanced disease. It has helped some patients achieve long-term remissions that were not possible just a decade ago. These treatments are now being used not just for advanced cancer, but also for earlier stages to help prevent the cancer from coming back after surgery.

It is important to have a care team that specializes in lung cancer. Treatment today is far more personalized than it used to be. Your doctor will look at the type of lung cancer you have, its stage, its genetic makeup, and your overall health to create a plan that is right for you. The field is moving fast, and new treatments are being approved regularly, meaning that options available today are better than those from just a few years ago, and tomorrow's options may be better still.